AA
Aardvark Therapeutics, Inc.
Nasdaq : AARDHealthcare · Pharmaceutical Preparations
Mkt Cap$117.74MShares Out21.88M30d Avg Vol31.43MShort Int—Short Float—IPOFeb 13, 2025
▲+7.71%
$73.36
No filed financial statements
Aardvark Therapeutics, Inc. (AARD) has not filed an annual report (Form 10-K) with the SEC, so audited financial statements aren't available yet. This is expected for recently public, private, or foreign-listed companies — figures will populate automatically once the company files. We don't show estimated or placeholder statements here.